Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

Correspondence for "Clinical epidemiology of familial sarcoidosis: A systematic literature review".

Rossides M, Grunewald J, Eklund A, Kullberg S, Askling J, Arkema EV.

Respir Med. 2019 May 13. pii: S0954-6111(19)30155-6. doi: 10.1016/j.rmed.2019.05.003. [Epub ahead of print] No abstract available.

PMID:
31104964
2.

Infections increase the risk of developing Sjögren's syndrome.

Mofors J, Arkema EV, Björk A, Westermark L, Kvarnström M, Forsblad-d'Elia H, Magnusson Bucher S, Eriksson P, Mandl T, Nordmark G, Wahren-Herlenius M.

J Intern Med. 2019 Jun;285(6):670-680. doi: 10.1111/joim.12888. Epub 2019 Apr 17.

PMID:
30892751
3.

Risk of serious infections in patients with rheumatoid arthritis treated in routine care with abatacept, rituximab and tocilizumab in Denmark and Sweden.

Grøn KL, Arkema EV, Glintborg B, Mehnert F, Østergaard M, Dreyer L, Nørgaard M, Krogh NS, Askling J, Hetland ML; ARTIS Study Group.

Ann Rheum Dis. 2019 Mar;78(3):320-327. doi: 10.1136/annrheumdis-2018-214326. Epub 2019 Jan 5.

PMID:
30612115
4.

Epidemiology of sarcoidosis: current findings and future directions.

Arkema EV, Cozier YC.

Ther Adv Chronic Dis. 2018 Aug 24;9(11):227-240. doi: 10.1177/2040622318790197. eCollection 2018 Nov. Review.

5.

Work ability before and after sarcoidosis diagnosis in Sweden.

Arkema EV, Eklund A, Grunewald J, Bruze G.

Respir Med. 2018 Nov;144S:S7-S12. doi: 10.1016/j.rmed.2018.09.016. Epub 2018 Oct 5.

PMID:
30343984
6.

The Risk of Ischemic and Haemorrhagic Stroke in Idiopathic Inflammatory Myopathies: a Swedish population-based cohort study.

Svensson J, Lundberg IE, Von Euler M, Arkema EV, Holmqvist M.

Arthritis Care Res (Hoboken). 2018 Jul 12. doi: 10.1002/acr.23702. [Epub ahead of print]

PMID:
29999244
7.

Dr. Rossides, et al reply.

Rossides M, Simard JF, Svenungsson E, VON Euler M, Arkema EV.

J Rheumatol. 2018 Jul;45(7):1070. doi: 10.3899/jrheum.180122. No abstract available.

PMID:
29961679
8.

Familial aggregation and heritability of sarcoidosis: a Swedish nested case-control study.

Rossides M, Grunewald J, Eklund A, Kullberg S, Di Giuseppe D, Askling J, Arkema EV.

Eur Respir J. 2018 Aug 16;52(2). pii: 1800385. doi: 10.1183/13993003.00385-2018. Print 2018 Aug.

PMID:
29946010
9.

Childhood death rates declined in Sweden from 2000 to 2014 but deaths from external causes were not always investigated.

Otterman G, Lahne K, Arkema EV, Lucas S, Janson S, Hellström-Westas L.

Acta Paediatr. 2019 Jan;108(1):160-168. doi: 10.1111/apa.14309. Epub 2018 Apr 6.

PMID:
29520820
10.

Sarcoidosis mortality in Sweden: a population-based cohort study.

Rossides M, Kullberg S, Askling J, Eklund A, Grunewald J, Arkema EV.

Eur Respir J. 2018 Feb 21;51(2). pii: 1701815. doi: 10.1183/13993003.01815-2017. Print 2018 Feb.

11.

Tuberculosis Risk in Ankylosing Spondylitis, Other Spondyloarthritis, and Psoriatic Arthritis in Sweden: A Population-Based Cohort Study.

de Vries MK, Arkema EV, Jonsson J, Bruchfeld J, Jacobsson LTH, Askling J; ARTIS Study Group.

Arthritis Care Res (Hoboken). 2018 Oct;70(10):1563-1567. doi: 10.1002/acr.23487. Epub 2018 Sep 4.

PMID:
29195024
12.

Response to: 'Increased stroke incidence in systemic lupus erythematosus patients: risk factors or disease itself?' by Bruzzese and Zullo.

Arkema EV, Rossides M, Von Euler M, Svenungsson E, Sjöwall C, Simard JF.

Ann Rheum Dis. 2018 Oct;77(10):e72. doi: 10.1136/annrheumdis-2017-212604. Epub 2017 Nov 16. No abstract available.

PMID:
29146744
13.

Asthma in Children of Mothers With Systemic Lupus Erythematosus and the Role of Preterm Birth.

Rossides M, Nguyen C, Arkema EV, Simard JF.

Arthritis Care Res (Hoboken). 2018 Aug;70(8):1269-1274. doi: 10.1002/acr.23472. Epub 2018 Jul 3.

PMID:
29125902
14.

Mortality and Functionality after Stroke in Patients with Systemic Lupus Erythematosus.

Rossides M, Simard JF, Svenungsson E, von Euler M, Arkema EV.

J Rheumatol. 2017 Nov;44(11):1590-1596. doi: 10.3899/jrheum.170241. Epub 2017 Sep 15.

PMID:
28916550
15.

Infections and respiratory tract disease as risk factors for idiopathic inflammatory myopathies: a population-based case-control study.

Svensson J, Holmqvist M, Lundberg IE, Arkema EV.

Ann Rheum Dis. 2017 Nov;76(11):1803-1808. doi: 10.1136/annrheumdis-2017-211174. Epub 2017 Aug 30.

PMID:
28855175
16.

Stroke in systemic lupus erythematosus: a Swedish population-based cohort study.

Arkema EV, Svenungsson E, Von Euler M, Sjöwall C, Simard JF.

Ann Rheum Dis. 2017 Sep;76(9):1544-1549. doi: 10.1136/annrheumdis-2016-210973. Epub 2017 Apr 11.

17.

Incidence and prevalence of idiopathic inflammatory myopathies in Sweden: a nationwide population-based study.

Svensson J, Arkema EV, Lundberg IE, Holmqvist M.

Rheumatology (Oxford). 2017 May 1;56(5):802-810. doi: 10.1093/rheumatology/kew503.

PMID:
28160487
18.

Cervical neoplasia in systemic lupus erythematosus: a nationwide study.

Wadström H, Arkema EV, Sjöwall C, Askling J, Simard JF.

Rheumatology (Oxford). 2017 Apr 1;56(4):613-619. doi: 10.1093/rheumatology/kew459.

19.

Medication use among pregnant women with systemic lupus erythematosus and general population comparators.

Palmsten K, Simard JF, Chambers CD, Arkema EV.

Rheumatology (Oxford). 2017 Apr 1;56(4):561-569. doi: 10.1093/rheumatology/kew448.

20.

Early-onset Preeclampsia in Lupus Pregnancy.

Simard JF, Arkema EV, Nguyen C, Svenungsson E, Wikström AK, Palmsten K, Salmon JE.

Paediatr Perinat Epidemiol. 2017 Jan;31(1):29-36. doi: 10.1111/ppe.12332. Epub 2016 Dec 12.

21.

Elevated BMI and antibodies to citrullinated proteins interact to increase rheumatoid arthritis risk and shorten time to diagnosis: A nested case-control study of women in the Nurses' Health Studies.

Tedeschi SK, Cui J, Arkema EV, Robinson WH, Sokolove J, Lingampalli N, Sparks JA, Karlson EW, Costenbader KH.

Semin Arthritis Rheum. 2017 Jun;46(6):692-698. doi: 10.1016/j.semarthrit.2016.09.001. Epub 2016 Sep 13.

22.

Induction maintenance with tumour necrosis factor-inhibitor combination therapy with discontinuation versus methotrexate monotherapy in early rheumatoid arthritis: a systematic review and meta-analysis of efficacy in randomised controlled trials.

Emamikia S, Arkema EV, Györi N, Detert J, Chatzidionysiou K, Dougados M, Burmester GR, van Vollenhoven R.

RMD Open. 2016 Sep 6;2(2):e000323. doi: 10.1136/rmdopen-2016-000323. eCollection 2016.

23.

Brief Report: Sex Ratio of Offspring Born to Women With Systemic Lupus Erythematosus or Rheumatoid Arthritis.

Arkema EV, Askling J, Salmon JE, Simard JF.

Arthritis Rheumatol. 2017 Jan;69(1):143-147. doi: 10.1002/art.39843. Epub 2016 Dec 2.

24.

Sarcoidosis incidence and prevalence: a nationwide register-based assessment in Sweden.

Arkema EV, Grunewald J, Kullberg S, Eklund A, Askling J.

Eur Respir J. 2016 Dec;48(6):1690-1699. doi: 10.1183/13993003.00477-2016. Epub 2016 Jul 28.

25.

What to Expect When Expecting With Systemic Lupus Erythematosus (SLE): A Population-Based Study of Maternal and Fetal Outcomes in SLE and Pre-SLE.

Arkema EV, Palmsten K, Sjöwall C, Svenungsson E, Salmon JE, Simard JF.

Arthritis Care Res (Hoboken). 2016 Jul;68(7):988-94. doi: 10.1002/acr.22791.

26.

Cancer risk in patients with spondyloarthritis treated with TNF inhibitors: a collaborative study from the ARTIS and DANBIO registers.

Hellgren K, Dreyer L, Arkema EV, Glintborg B, Jacobsson LT, Kristensen LE, Feltelius N, Hetland ML, Askling J; ARTIS Study Group, For the DANBIO Study Group.

Ann Rheum Dis. 2017 Jan;76(1):105-111. doi: 10.1136/annrheumdis-2016-209270. Epub 2016 May 4.

PMID:
27147709
27.

Endometriosis and systemic lupus erythematosus: a population-based case-control study.

Harris HR, Simard JF, Arkema EV.

Lupus. 2016 Aug;25(9):1045-9. doi: 10.1177/0961203316631635. Epub 2016 Feb 6.

28.

Case definitions in Swedish register data to identify systemic lupus erythematosus.

Arkema EV, Jönsen A, Rönnblom L, Svenungsson E, Sjöwall C, Simard JF.

BMJ Open. 2016 Jan 4;6(1):e007769. doi: 10.1136/bmjopen-2015-007769.

29.

Stroke in systemic lupus erythematosus: a meta-analysis of population-based cohort studies.

Holmqvist M, Simard JF, Asplund K, Arkema EV.

RMD Open. 2015 Dec 16;1(1):e000168. doi: 10.1136/rmdopen-2015-000168. eCollection 2015. Review.

30.

Cohort profile: systemic lupus erythematosus in Sweden: the Swedish Lupus Linkage (SLINK) cohort.

Arkema EV, Simard JF.

BMJ Open. 2015 Aug 14;5(8):e008259. doi: 10.1136/bmjopen-2015-008259.

31.

Monocyte chemotactic protein-1 elevation prior to the onset of rheumatoid arthritis among women.

Arkema EV, Lu B, Malspeis S, Karlson EW, Costenbader KH.

Biomark Med. 2015;9(8):723-9. doi: 10.2217/BMM.15.40. Epub 2015 Jul 30.

32.

Perinatal risk factors for future SLE: a population-based nested case-control study.

Arkema EV, Simard JF.

Lupus. 2015 Jul;24(8):869-74. doi: 10.1177/0961203315570160. Epub 2015 Feb 10.

PMID:
25672372
33.

The Swedish Rheumatology Quality Register: optimisation of rheumatic disease assessments using register-enriched data.

Eriksson JK, Askling J, Arkema EV.

Clin Exp Rheumatol. 2014 Sep-Oct;32(5 Suppl 85):S-147-9. Epub 2014 Oct 30.

PMID:
25365105
34.

No association between rheumatoid arthritis, amyotrophic lateral sclerosis, and tumour necrosis factor inhibitor treatment.

Arkema EV, Feltelius N, Olsson T, Askling J; ARTIS study group.

Ann Rheum Dis. 2014 Nov;73(11):2061-2. doi: 10.1136/annrheumdis-2014-205622. Epub 2014 Aug 5. No abstract available.

PMID:
25096786
35.

Circulating 25-hydroxyvitamin D level and risk of developing rheumatoid arthritis.

Hiraki LT, Arkema EV, Cui J, Malspeis S, Costenbader KH, Karlson EW.

Rheumatology (Oxford). 2014 Dec;53(12):2243-8. doi: 10.1093/rheumatology/keu276. Epub 2014 Jul 26.

36.

Being overweight or obese and risk of developing rheumatoid arthritis among women: a prospective cohort study.

Lu B, Hiraki LT, Sparks JA, Malspeis S, Chen CY, Awosogba JA, Arkema EV, Costenbader KH, Karlson EW.

Ann Rheum Dis. 2014 Nov;73(11):1914-22. doi: 10.1136/annrheumdis-2014-205459. Epub 2014 Jul 23.

37.

Are patients with rheumatoid arthritis still at an increased risk of tuberculosis and what is the role of biological treatments?

Arkema EV, Jonsson J, Baecklund E, Bruchfeld J, Feltelius N, Askling J; ARTIS Study Group.

Ann Rheum Dis. 2015 Jun;74(6):1212-7. doi: 10.1136/annrheumdis-2013-204960. Epub 2014 Mar 7.

PMID:
24608401
38.

Anti-citrullinated peptide autoantibodies, human leukocyte antigen shared epitope and risk of future rheumatoid arthritis: a nested case-control study.

Arkema EV, Goldstein BL, Robinson W, Sokolove J, Wagner CA, Malspeis S, Rosner B, Grodstein F, Karlson EW, Costenbader KH.

Arthritis Res Ther. 2013 Oct 23;15(5):R159. doi: 10.1186/ar4342.

39.

Drug survival on TNF inhibitors in patients with rheumatoid arthritis comparison of adalimumab, etanercept and infliximab.

Neovius M, Arkema EV, Olsson H, Eriksson JK, Kristensen LE, Simard JF, Askling J; ARTIS Study Group.

Ann Rheum Dis. 2015 Feb;74(2):354-60. doi: 10.1136/annrheumdis-2013-204128. Epub 2013 Nov 27.

40.

Exposure to ultraviolet-B and risk of developing rheumatoid arthritis among women in the Nurses' Health Study.

Arkema EV, Hart JE, Bertrand KA, Laden F, Grodstein F, Rosner BA, Karlson EW, Costenbader KH.

Ann Rheum Dis. 2013 Apr;72(4):506-11. doi: 10.1136/annrheumdis-2012-202302. Epub 2013 Feb 4.

41.

Patients with ulcerative colitis miss more days of work than the general population, even following colectomy.

Neovius M, Arkema EV, Blomqvist P, Ekbom A, Smedby KE.

Gastroenterology. 2013 Mar;144(3):536-43. doi: 10.1053/j.gastro.2012.12.004. Epub 2012 Dec 8.

PMID:
23232295
42.

Incidence of progressive multifocal leukoencephalopathy in patients with rheumatoid arthritis: a national population-based study.

Arkema EV, van Vollenhoven RF, Askling J; ARTIS Study Group.

Ann Rheum Dis. 2012 Nov;71(11):1865-7. doi: 10.1136/annrheumdis-2012-201638. Epub 2012 Jun 27.

PMID:
22739991
43.

Is there a sex bias in prescribing anti-tumour necrosis factor medications to patients with rheumatoid arthritis? A nation-wide cross-sectional study.

Arkema EV, Neovius M, Joelsson JK, Simard JF, van Vollenhoven RF.

Ann Rheum Dis. 2012 Jul;71(7):1203-6. doi: 10.1136/annrheumdis-2011-200947. Epub 2012 Apr 13.

PMID:
22504565
44.

Ten years with biologics: to whom do data on effectiveness and safety apply?

Simard JF, Arkema EV, Sundström A, Geborek P, Saxne T, Baecklund E, Coster L, Dackhammar C, Jacobsson L, Feltelius N, Lindblad S, Rantapää-Dahlqvist S, Klareskog L, van Vollenhoven RF, Neovius M, Askling J.

Rheumatology (Oxford). 2011 Jan;50(1):204-13. doi: 10.1093/rheumatology/keq326. Epub 2010 Nov 16.

PMID:
21084326
45.

A prospective study of periodontal disease and risk of rheumatoid arthritis.

Arkema EV, Karlson EW, Costenbader KH.

J Rheumatol. 2010 Sep;37(9):1800-4. doi: 10.3899/jrheum.091398. Epub 2010 Jul 1.

46.

Efficacy of initial methotrexate monotherapy versus combination therapy with a biological agent in early rheumatoid arthritis: a meta-analysis of clinical and radiographic remission.

Kuriya B, Arkema EV, Bykerk VP, Keystone EC.

Ann Rheum Dis. 2010 Jul;69(7):1298-304. doi: 10.1136/ard.2009.118307. Epub 2010 Apr 26. Review.

PMID:
20421343

Supplemental Content

Loading ...
Support Center